智翔金泰：自赛立奇单抗注射液纳入国家医保目录后，产品准入效率得到显著提升

Group 1 - The core viewpoint of the article highlights the positive impact of the inclusion of the drug "赛立奇单抗" in the national medical insurance directory, which has significantly improved the product's access efficiency [1] - The company, 智翔金泰, is committed to actively promoting the access work to enhance drug availability and aims to benefit more patients [1]